Minocycline in MS: Confirmation of Benefit

NCT04291456 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Completion is not possible due to recruitment concerns

Conditions

Multiple Sclerosis
Clinically Isolated Syndrome

Interventions

DRUG: Minocycline 100mg

Sponsor

University of Calgary

Collaborators

[object Object]
[object Object]